Melanocytes and melanoma tumor cells from melanoma patients are hypersensitive to oxidizing agents, due to an endogenous antioxidant imbalance [15,16], and loss-of-function polymorphisms of glutathione S-transferase (GST) antioxidant genes are associated with increased melanoma risk [17]. The gene discussed is HPGDS; the disease is melanoma.